THE ANTITHROMBOTIC AND BLEEDING EFFECTS OF DABIGATRAN, A DIRECT THROMBIN INHIBITOR, AS COMPARED TO ENOXAPARIN, HEPARIN AND WARFARIN IN RATS

被引：0
|
作者：
Van Ryn, J. [1 ]
Kuritsch, I. [1 ]
Kink-Eiband, M. [1 ]
Priepke, H. [1 ]
Wienen, W. [1 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1011
引用
收藏
页码：407 / 407
页数：1
相关论文
共 50 条
  • [41] Advances in Anticoagulation: Focus on Dabigatran, an Oral Direct Thrombin Inhibitor
    Augoustides, John G. T.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2011, 25 (06) : 1208 - 1212
  • [42] Our 5 Year Experience with the Risk of Gastrointestinal Bleeding in Dabigatran Compared to Warfarin
    Jiang, Chunsu
    Sherid, Muhammed
    Sayed, Amer
    Lee, Jai Eun
    Bhagatwala, Jigar
    Patel, Harsh
    Oh, Sun Jung
    Sridhar, Subbaramiah
    Sifuentes, Humberto
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB280 - AB281
  • [43] Neither dabigatran nor rivaroxaban was linked to increased GI bleeding compared with warfarin
    Koretz, Ronald L.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
  • [44] Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
    Aalbers, J.
    CARDIOVASCULAR JOURNAL OF AFRICA, 2010, 21 (03) : 173 - U54
  • [45] Safety and efficacy of a new oral direct thrombin inhibitor Dabigatran in atrial fibrillation - a dose finding trial with comparison to Warfarin
    Wallentin, L. C.
    Ezekowitz, M.
    Simmers, T. A.
    Pedersen, K. E.
    Stangier, J.
    Nehmiz, G.
    Reilly, P.
    EUROPEAN HEART JOURNAL, 2005, 26 : 482 - 483
  • [46] Single-center Experience with Gastrointestinal Bleeding in Patients Taking the New Oral Direct Thrombin Inhibitor Dabigatran
    Kaszubowski, Martin
    Harrison, Stephen
    Cunningham, John
    Francis, James
    Krier, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S492 - S492
  • [47] Effects of recombinant factor VIIa on the antithrombotic and bleeding time effects of SS457, a direct factor Xa inhibitor, in rats
    Wong, PC
    Pinto, DJ
    Knabb, RM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E65 - E65
  • [48] Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits
    Wong, P. C.
    Crain, E. J.
    Watson, C. A.
    Xin, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) : 1313 - 1320
  • [49] Introduction of a thrombin sensor based on its interaction with dabigatran as an oral direct thrombin inhibitor
    Paimard, Giti
    Gholivand, Mohammad Bagher
    Shamsipur, Mojtaba
    Ahmadi, Elahe
    Shahlaei, Mohsen
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2021, 119
  • [50] COMPARING THE ANTITHROMBOTIC EFFECTS OF HEPARIN, ENOXAPARIN AND PROSTACYCLIN DURING CONTINUOUS HEMOFILTRATION
    JOURNOIS, D
    SAFRAN, D
    CASTELAIN, MH
    CHANU, D
    DREVILLON, C
    BARRIER, G
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1990, 9 (04): : 331 - 337
12345